ClomiPRAMINE Hydrochloride Capsules, USP 25mg, 100-count bottles, Rx only, LEADING PHARMA, Manufactured by: Leading Pharma, LLC, Fairfield, NJ 07004, NDC 69315-167-01
Published October 5, 2022 · Recall initiated: August 23, 2022
Summary
FDA records drug Class III recall D-1546-2022, published October 5, 2022 and initiated August 23, 2022. Recalling firm: Leading Pharma, LLC; Status: Terminated; Reported quantity: 960 bottles (100 capsules); Lot: Lot#: B14221, Exp. Date 02/2023. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Superpotent Drug: Assay value found to be 110.6% in Chlomipramine Hydrocholoride capsules
What to do
Voluntary: Firm initiated · Letter
Get an email if CLOMIPRAMINE HYDROCHLORIDE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- CLOMIPRAMINE HYDROCHLORIDE
- Manufacturer
- Leading Pharma, LLC
- Distributor
- Nationwide within the United States
- UPC
- 0369315167014
- Lot
- Lot#: B14221, Exp. Date 02/2023
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAclomiPRAMINE Hydrochloride, Capsules, USP, 50 mg, packaged in a) 30-count bottles (NDC 16714-850-01), b)November 12, 2025
- FDAclomiPRAMINE Hydrochloride, Capsules, USP, 25 mg, packaged in a) 30-count bottles (NDC 16714-849-01), b)November 12, 2025
- FDAclomiPRAMINE Hydrochloride, Capsules, USP, 75 mg, packaged in a) 30-count bottles (NDC 16714-851-01), b)November 12, 2025
- FDAclomiPRAMINE Hydrochloride Capsules USP 25 mg, 100 count bottles, 5801 Pelican Bay Boulevard, Suite 500,July 30, 2025
- FDABudesonide Inhalation Suspension 0.25mg/2mL, For Inhalation Only, Rx Only, 1 envelope x five 2 mL Single DoseOctober 5, 2022
- FDARifampin Capsules, USP, 150 mg, 30-count bottle, Rx only, Distributed by: Akorn Operating Company, LLC,October 5, 2022
Questions about this recall
Was ClomiPRAMINE Hydrochloride Capsules, USP 25mg, 100-count bottles, Rx only, LEADING PHARMA, Manufactured by: Leading Pharma, LLC, Fairfield, NJ 07004, NDC 69315-167-01 recalled?
Yes. FDA published recall D-1546-2022 on October 5, 2022. Reported hazard: Superpotent Drug: Assay value found to be 110.6% in Chlomipramine Hydrocholoride capsules
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: CLOMIPRAMINE HYDROCHLORIDE. UPC: 0369315167014.